Effect of rhBNP on CMD in Patients With STEMI After PPCI

NANot yet recruitingINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

February 20, 2023

Primary Completion Date

December 20, 2024

Study Completion Date

December 20, 2025

Conditions

STEMI

Interventions

DRUG

recombinant human B-type natriuretic peptide

The recombinant human B-type natriuretic peptide produces physiological effects by imitating endogenous B-type natriuretic peptide

All Listed Sponsors

lead

Henan Institute of Cardiovascular Epidemiology

OTHER

NCT05723315 - Effect of rhBNP on CMD in Patients With STEMI After PPCI | Biotech Hunter | Biotech Hunter